vs
Side-by-side financial comparison of SenesTech, Inc. (SNES) and SciSparc Ltd. (SPRC). Click either name above to swap in a different company.
SciSparc Ltd. is the larger business by last-quarter revenue ($461.0K vs $421.0K, roughly 1.1× SenesTech, Inc.). SenesTech, Inc. runs the higher net margin — -428.5% vs -2041.6%, a 1613.1% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -45.1%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapies for unmet medical needs in the neurological, psychiatric, and gastrointestinal disorder segments. It operates across global biotech markets, leveraging proprietary cannabinoid-based formulation technologies to advance its pipeline of therapeutic candidates.
SNES vs SPRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $421.0K | $461.0K |
| Net Profit | $-1.8M | $-9.4M |
| Gross Margin | 55.3% | 78.1% |
| Operating Margin | -446.8% | -588.5% |
| Net Margin | -428.5% | -2041.6% |
| Revenue YoY | -16.0% | -45.1% |
| Net Profit YoY | -43.7% | -155.8% |
| EPS (diluted) | $0.48 | $17.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $421.0K | — | ||
| Q3 25 | $690.0K | — | ||
| Q2 25 | $625.0K | $461.0K | ||
| Q1 25 | $485.0K | — | ||
| Q4 24 | $501.0K | $466.0K | ||
| Q3 24 | $482.0K | — | ||
| Q2 24 | $459.0K | $840.0K | ||
| Q1 24 | $415.0K | — |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-1.6M | $-9.4M | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.3M | $-3.8M | ||
| Q3 24 | $-1.5M | — | ||
| Q2 24 | $-1.6M | $-3.7M | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | 55.3% | — | ||
| Q3 25 | 62.8% | — | ||
| Q2 25 | 65.4% | 78.1% | ||
| Q1 25 | 64.5% | — | ||
| Q4 24 | 60.9% | 6.9% | ||
| Q3 24 | 65.4% | — | ||
| Q2 24 | 54.2% | 56.4% | ||
| Q1 24 | 32.5% | — |
| Q4 25 | -446.8% | — | ||
| Q3 25 | -195.2% | — | ||
| Q2 25 | -258.2% | -588.5% | ||
| Q1 25 | -342.9% | — | ||
| Q4 24 | -250.9% | -813.1% | ||
| Q3 24 | -321.0% | — | ||
| Q2 24 | -349.0% | -419.9% | ||
| Q1 24 | -444.1% | — |
| Q4 25 | -428.5% | — | ||
| Q3 25 | -188.1% | — | ||
| Q2 25 | -258.6% | -2041.6% | ||
| Q1 25 | -343.3% | — | ||
| Q4 24 | -250.5% | -813.9% | ||
| Q3 24 | -313.9% | — | ||
| Q2 24 | -345.1% | -438.0% | ||
| Q1 24 | -441.4% | — |
| Q4 25 | $0.48 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.87 | $17.92 | ||
| Q1 25 | $-1.28 | — | ||
| Q4 24 | $-0.15 | $-8.82 | ||
| Q3 24 | $-2.07 | — | ||
| Q2 24 | $-3.08 | $35.70 | ||
| Q1 24 | $-3.56 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.6M | $-81.0K |
| Total Assets | $12.8M | $5.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $6.1M | $1.5M | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $1.3M | $1.5M | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $2.0M | $252.0K | ||
| Q1 24 | $3.6M | — |
| Q4 25 | $9.6M | — | ||
| Q3 25 | $11.3M | — | ||
| Q2 25 | $7.0M | $-81.0K | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $2.5M | $8.9M | ||
| Q3 24 | $3.7M | — | ||
| Q2 24 | $3.1M | $8.7M | ||
| Q1 24 | $4.6M | — |
| Q4 25 | $12.8M | — | ||
| Q3 25 | $14.6M | — | ||
| Q2 25 | $10.4M | $5.1M | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $3.3M | $10.3M | ||
| Q3 24 | $4.4M | — | ||
| Q2 24 | $4.0M | $10.5M | ||
| Q1 24 | $5.5M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-1.9M |
| Free Cash FlowOCF − Capex | $-1.7M | — |
| FCF MarginFCF / Revenue | -398.3% | — |
| Capex IntensityCapex / Revenue | 3.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $-1.1M | $-1.9M | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-1.2M | $-2.9M | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-1.6M | $-2.2M | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-1.6M | $-2.2M | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | -398.3% | — | ||
| Q3 25 | -205.9% | — | ||
| Q2 25 | -191.5% | — | ||
| Q1 25 | -328.5% | — | ||
| Q4 24 | -246.1% | — | ||
| Q3 24 | -296.1% | — | ||
| Q2 24 | -354.2% | -261.7% | ||
| Q1 24 | -441.2% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 6.1% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 8.5% | 0.1% | ||
| Q1 24 | 0.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
